treatment guidelines

Research in Review

American College of Cardiology Releases Consensus-Driven Decision Pathway for TAVR

02/13/2017

JCP Editors

The American College of Cardiology (ACC) has issued a decision pathway to for the selection, treatment, and follow-up care of patients with aortic stenosis who may be candidates for transcatheter aortic valve...

The...

02/13/2017

Journal of Clinical Pathways

Research in Review

Response to Chemo Helps Decide Optimal Treatment Course for Patients With Laryngeal Cancer

02/10/2017

JCP Editors

Response to a single dose of neoadjuvant chemotherapy indicates the optimal treatment course for patients with laryngeal cancer, according to a study published in JAMA Otolaryngology (published online February 2,...

...

02/10/2017

Journal of Clinical Pathways

Research in Review

Less-Frequent Dosing Noninferior to Standard Dosing of Bone-Modifying Agent for Breast Cancer

01/30/2017

JCP Editors

A less-frequent dosing schedule of a bone-modifying agent (BMA) for treatment of skeletal-related events related to metastatic breast cancer is noninferior to standard dosing, according to research published in JAMA...

A...

01/30/2017

Journal of Clinical Pathways

Research in Review

Precision Medicine Approach Effective in Evaluating Pediatric Brain Tumors

01/20/2017

JCP Editors

A combination of genomic assays could be an effective precision medicine approach for clinical diagnosis, prognosis, and treatment guidance of pediatric brain tumors, according to new research published in...

A...

01/20/2017

Journal of Clinical Pathways

Research in Review

Novel Biomarker Helps Detect Blood Cancer Responders to Chemotherapy

01/13/2017

JCP Editors

Expression of a cellular enzyme could predict the response of patients with acute myeloid leukemia (AML) to chemotherapy, according to new research. ----- Related Content Personalized Genomic Framework Predicts...

...

01/13/2017

Journal of Clinical Pathways

Research in Review

Emotional Distress May Lead to Unnecessary Treatment for Prostate Cancer

01/11/2017

JCP Editors

Men diagnosed with prostate cancer may become distressed and consequently choose unnecessarily aggressive treatment options, according to a new study published in the Journal of Oncology. Prostate cancer is a highly...

Men...

01/11/2017

Journal of Clinical Pathways

Research in Review

Prophylactic Treatment Reduces Toxicity in HER2+ Breast Cancer

01/11/2017

JCP Editors

Loperamide plus budesonide reduces the rate of toxic effects associated with neratinib for patients with human epidermal growth factor receptor-2 positive (HER2+) breast cancer, according to the results of a trial...

...

01/11/2017

Journal of Clinical Pathways

Research in Review

Most Cost-Effective Sequence of TKIs for Treatment of GISTs Identified

01/10/2017

JCP Editors

The best potential strategy involving tyrosine kinase inhibitors (TKIs) for the treatment of gastrointestinal stromal tumors (GISTs) has been identified, according to new research published in Clinical Drug...

The...

01/10/2017

Journal of Clinical Pathways

Research in Review

Precision Medicine Increasingly Guides Decision-Making for Patients with Breast Cancer

12/29/2016

JCP Editors

Breast cancer serves as a model for using precision medicine to guide treatment decisions and improve patients’ quality of life, according to a presentation at the 2016 Lynn Sage Breast Cancer...

Breast...

12/29/2016

Journal of Clinical Pathways

Research in Review

Varying Toxicities Between EGFR-TKIs for Treatment of NSCLC

12/29/2016

JCP Editors

Varying degrees of toxicity risks between different epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) can help inform treatment decisions for individual patients with non-small cell lung...

...

12/29/2016

Journal of Clinical Pathways